Eric Joseph
Stock Analyst at JP Morgan
(2.86)
Main Sectors:
49 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
KYMR Kymera Therapeutics | Maintains: Overweight | 57 64 | 57.57 | 11.17% | 4 | Jun 3, 2025 | |
PRME Prime Medicine | Downgrades: Neutral | n/a | n/a | n/a | 5 | May 20, 2025 | |
RCKT Rocket Pharmaceutica... | Maintains: Overweight | 45 44 | 3.17 | 1288.01% | 3 | May 9, 2025 | |
NVAX Novavax | Maintains: Underweight | 9 7 | 9.3 | -24.73% | 8 | May 9, 2025 | |
PTCT PTC Therapeutics | Maintains: Overweight | 75 67 | 64.83 | 3.35% | 10 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 4 | Apr 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 3 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Feb 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 30 | 10.15 | 195.57% | 7 | Jan 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 8 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 14 | 5.62 | 149.11% | 5 | Jan 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 63 71 | 46.5 | 52.69% | 6 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 43 | 37.03 | 16.12% | 4 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 38 | 21.11 | 80.01% | 1 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 23 | 3.26 | 605.52% | 1 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 7.1 | 139.44% | 2 | Oct 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 21 | 5.66 | 271.02% | 5 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 48 | 26.1 | 83.91% | 3 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 11 10 | 11.18 | -10.55% | 4 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 15 | 2.59 | 479.15% | 1 | May 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 6 | 2.31 | 159.74% | 4 | Jan 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 25 15 | n/a | n/a | 2 | Nov 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 11 10 | 5.63 | 77.62% | 2 | Nov 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 11 | 7.55 | 45.7% | 2 | Oct 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 62 41 | 45.82 | -10.52% | 2 | Oct 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 300 100 | 17.75 | 463.38% | 1 | Aug 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 5 | 0.54 | 825.93% | 2 | Aug 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 6 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 11 | 8.22 | 33.82% | 6 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 94 65 | n/a | n/a | 1 | Dec 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Nov 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 120 | 6.32 | 1798.73% | 2 | Feb 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 750 300 | 10.14 | 2858.58% | 2 | Jan 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Oct 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 1 | Sep 9, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 405 120 | n/a | n/a | 2 | Aug 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 50 | n/a | n/a | 1 | Jul 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underweight | 11 | n/a | n/a | 1 | Apr 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 133 153 | n/a | n/a | 2 | Jan 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 9 | 1.55 | 480.65% | 2 | Jan 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Jan 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 16 | n/a | n/a | 2 | Nov 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 14 | n/a | n/a | 3 | Nov 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 3 | Nov 9, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 42 | 3.96 | 960.61% | 1 | Feb 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 30 | n/a | n/a | 3 | Jan 15, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 11 13 | 1.5 | 766.67% | 2 | Jan 24, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 35 11 | 0.69 | 1494.2% | 2 | Nov 14, 2018 |